{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:18:01Z","timestamp":1792001881117,"version":"4.4.0"},"reference-count":76,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>To summarize and extend the main conclusions and recommendations relevant to drug management during acute kidney disease (AKD) as agreed at the 16<jats:sup>th<\/jats:sup> Acute Disease Quality Initiative (ADQI) consensus conference.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Using a modified Delphi method to achieve consensus, experts attending the 16<jats:sup>th<\/jats:sup> ADQI consensus conference reviewed and appraised the existing literature on drug management during AKD and identified recommendations for clinical practice and future research. The group focussed on drugs with one of the following characteristics: (i) predominant renal excretion; (ii) nephrotoxicity; (iii) potential to alter glomerular function; and (iv) presence of metabolites that are modified in AKD and may affect other organs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We recommend that medication reconciliation should occur at admission and discharge, at AKD diagnosis and change in AKD phase, and when the patient's condition changes. Strategies to avoid adverse drug reactions in AKD should seek to minimize adverse events from overdosing and nephrotoxicity and therapeutic failure from under\u2010dosing or incorrect drug selection. Medication regimen assessment or introduction of medications during the AKD period should consider the nephrotoxic potential, altered renal and nonrenal elimination, the effects of toxic metabolites and drug interactions and altered pharmacodynamics in AKD. A dynamic monitoring plan including repeated serial assessment of clinical features, utilization of renal diagnostic tests and therapeutic drug monitoring should be used to guide medication regimen assessment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Drug management during different phases of AKD requires an individualized approach and frequent re\u2010assessment. More research is needed to avoid drug associated harm and therapeutic failure.<\/jats:p><\/jats:sec>","DOI":"10.1111\/bcp.13449","type":"journal-article","created":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T11:02:40Z","timestamp":1507719760000},"page":"396-403","source":"Crossref","is-referenced-by-count":55,"title":["Drug management in acute kidney disease \u2013 Report of the Acute Disease Quality Initiative XVI meeting"],"prefix":"10.1111","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9500-9080","authenticated-orcid":false,"given":"Marlies","family":"Ostermann","sequence":"first","affiliation":[{"name":"Department of Intensive Care King's College London, Guy's &amp; St Thomas' NHS Foundation Hospital  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakhmir S.","family":"Chawla","sequence":"additional","affiliation":[{"name":"Department of Medicine Veterans Affairs Medical Center  Washington DC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lui G.","family":"Forni","sequence":"additional","affiliation":[{"name":"Intensive Care Unit Royal Surrey County Hospital NHS Foundation Trust  Guildford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra L.","family":"Kane\u2010Gill","sequence":"additional","affiliation":[{"name":"University of Pittsburgh School of Pharmacy  Pittsburgh USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Kellum","sequence":"additional","affiliation":[{"name":"Center for Critical Care Nephrology, Department of Critical Care Medicine University of Pittsburgh  USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Koyner","sequence":"additional","affiliation":[{"name":"Department of Medicine University of Chicago  Chicago USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick T.","family":"Murray","sequence":"additional","affiliation":[{"name":"UCD School of Medicine, Health Sciences Centre University College Dublin  Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Ronco","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Dialysis and Transplantation San Bortolo Hospital, International Renal Research Institute of Vicenza  Vicenza Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart L.","family":"Goldstein","sequence":"additional","affiliation":[{"name":"Cincinnati Children's Hospital Medical Center Division of Nephrology and Hypertension  Cincinnati USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ADQI 16 workgroup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,12]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2011.12"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/0885066614555490"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu027"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e318241e553"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2011.322"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2017.2"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.06480612"},{"key":"e_1_2_6_9_1","unstructured":"Acute Dialysis Quality Initiative 16(www.adqi.org)"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2009.353"},{"key":"e_1_2_6_11_1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1177\/039139880803100202","article-title":"Acute dialysis quality initiative (ADQI): methodology","volume":"31","author":"Kellum JA","year":"2008","journal-title":"Int J Artif Organs"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2013.835802"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.374"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1159\/000349964"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-130-6-199903160-00002"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010111124"},{"key":"e_1_2_6_18_1","first-page":"837","article-title":"Creatinine clearance predictions in acutely ill patients","volume":"38","author":"Chrymko MM","year":"1981","journal-title":"Am J Hosp Pharm"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-005-2036-0"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012070653"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(71)92283-5"},{"key":"e_1_2_6_22_1","first-page":"315","article-title":"A new simple and rapid method to monitor the renal function based on pharmacokinetic consideration of endogeneous creatinine","volume":"10","author":"Chiou WL","year":"1975","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1985.101"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-012-0602-x"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2011.31"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2011.294"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-016-1478-z"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.90230.2008"},{"key":"e_1_2_6_29_1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000349967","article-title":"Physiological biomarkers of acute kidney injury: a conceptual approach to improving outcomes","volume":"182","author":"Okusa MD","year":"2013","journal-title":"Contrib Nephrol"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccc.2015.06.002"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002729"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05150512"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfs380"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013070742"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2011090907"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010121302"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.10971012"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201401-0077OC"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu292"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc12503"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014060556"},{"key":"e_1_2_6_42_1","first-page":"iii96","article-title":"Albuminuria increases cystatin C excretion: implications for urinary biomarkers","volume":"27","author":"Nejat M","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2012.23"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2011040325"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv130"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.2217\/bmm.13.51"},{"key":"e_1_2_6_47_1","article-title":"Prevention of cardiac surgery\u2010associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial","author":"Meersch M","year":"2017","journal-title":"Intensive Care Med"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfx016"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1159\/000452402"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0510-436"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw351"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-015-3934-7"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00927.x"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.2.212"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cger.2009.04.001"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2014.03.014"},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03261961"},{"key":"e_1_2_6_58_1","first-page":"691013","article-title":"Risk factors for development of acute kidney injury in critically ill patients: a systematic review and meta\u2010analysis of observational studies","volume":"2012","author":"Cartin\u2010Ceba R","year":"2012","journal-title":"Crit Care Res Pract"},{"issue":"12","key":"e_1_2_6_59_1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/01.ccm.0000474803.09991.3f","article-title":"975: a unique application of the grade criteria: drug\u2010combination associated Aki","volume":"43","author":"Rivosecchi R","year":"2015","journal-title":"Crit Care Med"},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-12-201306180-00004"},{"key":"e_1_2_6_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccc.2015.06.005"},{"key":"e_1_2_6_62_1","first-page":"1","article-title":"KDIGO clinical practice guideline for acute kidney injury","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group","year":"2012","journal-title":"Kidney Int"},{"key":"e_1_2_6_63_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.11921112"},{"key":"e_1_2_6_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1653"},{"key":"e_1_2_6_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2011.92"},{"key":"e_1_2_6_66_1","article-title":"Cumulative cardiovascular polypharmacy is associated with the risk of acute kidney injury in elderly patients","volume":"94","author":"Chao CT","year":"2015","journal-title":"Medicine"},{"key":"e_1_2_6_67_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f4930"},{"key":"e_1_2_6_68_1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e8525","article-title":"Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non\u2010steroidal anti\u2010inflammatory drugs and risk of acute kidney injury: nested case\u2010control study","volume":"346","author":"Lapi F","year":"2013","journal-title":"BMJ"},{"key":"e_1_2_6_69_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1641"},{"key":"e_1_2_6_70_1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078465","article-title":"ACE inhibitor and angiotensin receptor\u2010II antagonist prescribing and hospital admissions with acute kidney injury: a longitudinal ecological study","volume":"8","author":"Tomlinson LA","year":"2013","journal-title":"PLoS One"},{"key":"e_1_2_6_71_1","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012674","article-title":"What are the risks and benefits of temporarily discontinuing medications to prevent acute kidney injury? A systematic review and meta\u2010analysis","volume":"7","author":"Whiting P","year":"2017","journal-title":"BMJ Open"},{"key":"e_1_2_6_72_1","doi-asserted-by":"publisher","DOI":"10.1002\/jhm.2182"},{"key":"e_1_2_6_73_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000000739"},{"key":"e_1_2_6_74_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002210"},{"key":"e_1_2_6_75_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-014-3403-8"},{"key":"e_1_2_6_76_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms15022538"},{"key":"e_1_2_6_77_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/85.4.599"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbcp.13449","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.13449","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T09:41:37Z","timestamp":1695894097000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.13449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":76,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["10.1111\/bcp.13449"],"URL":"https:\/\/doi.org\/10.1111\/bcp.13449","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}